ALBIOMA : 2013 dividend

ALBIOMA

PRESS RELEASE
PARIS LA DÉFENSE, MAY 28, 2014

2013 DIVIDEND
Option for the payment of the dividend in the form of new shares of the Company

The General Meeting of shareholders held on May 27, 2014 approved the proposal of an option for the payment of 50% of the dividend to be distributed in respect of the 2013 financial year in the form of new shares of the Company. As a consequence, shareholders may opt for the payment of 50% of the €0.60 dividend distributed (i.e. €0.30 per share) in the form of new shares; should the option be exercised, the remaining dividend will be paid in cash.

The option may only be exercised for the entire fraction of the dividend to which the option refers (i.e. 50%) and in respect of which the option is exercised. The option must be exercised by shareholders from June 5, 2014 to June 20, 2014 inclusive, either by request to the financial intermediary in charge of the shareholder's securities account for bearer shares, or by request to BNP Paribas Securities Services as keeper of the Company's share registry for registered shares. After expiry of the aforementioned period, any shareholder failing to exercise the option shall receive payment of its entire dividend in cash, i.e. €0.60 per share.

The shares shall be listed ex-dividend as from June 5, 2014. The shares issued in payment of the dividend will be delivered on July 2, 2014, on the same date as the payment of the cash dividend.

The issuing price of the new shares that will be issued in payment of the dividend will correspond to 90% of the share price on the regulated market of NYSE Euronext in Paris during the twenty trading days prior to the decision to distribute, less the net dividend amount, and the amount resulting from this formula will be rounded up to the next cent, i.e. an issuing price of €17.44 per share.

If, on the basis of this price, the amount of the dividend to which a shareholder is entitled does not correspond to a whole number of shares, the shareholder may obtain the lower number of shares plus a cash balance.

Application will be made for the new shares to be admitted to trading on the regulated market of NYSE Euronext in Paris as from July 2, 2014. These new shares will be subject to the provisions of Albioma's Articles of Association. As a consequence, they will be fully assimilated to the existing shares of the Company.

Warning

This release constitutes the information document required under articles 212-4 (4°) and 212-5 (5°) of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) and under article 13 and exhibit III of the Instruction no. 2005-11 of December 13, 2005 as modified. This release does not constitute an offer to the public nor a solicitation to purchase or subscribe for securities.

This release and any other document related to the payment of the dividend in the form of new shares of the Company may not be published outside France, unless such publication complies with applicable local laws and regulations. Moreover, such publication may not constitute an offer to purchase or subscribe for securities, in any country where such an offer would break applicable local laws and regulations.

The option for payment of the dividend in the form of new shares of the Company shall not be available to any shareholder residing in Australia, in the United States of America, in Japan, in Italy or in any country where such an option would require a registration or an authorisation to be granted by local financial market authorities. Shareholders are expected to inform themselves on the applicable local laws and regulations applicable to the option.

When deciding whether or not they will exercise the option, shareholders are advised to take into account the risks associated with an investment in shares. For any further information about the Company, its business, its strategy, its financial results and position, please refer to the Registration Document of Albioma available on the Comany's Website, www.albioma.com, with particular focus on on chapter 1, pages 20 onwards "Risk factors and insurance policy".

Next on the agenda: release (post-trading) of results for the first half of the 2014 financial year, on July 22, 2014.

STAY UP-TO-DATE!

Register on our Website (sections Investors or Shareholders) to receive email alerts for our latest news online.

ABOUT ALBIOMA

Using its unique expertise in exploiting bagasse (a by-product of sugar cane), ALBIOMA is able to produce electric energy from every type of biomass through a cogeneration process. The Group is also a pioneer of agricultural anaerobic digestion in France. It's ambition is to be recognized as agri-businesses' partner of choice for turning biomass into a highly-effective source of energy without conflict over use. In addition, ALBIOMA develops and operates high-margin solar projects.

For further information, please visit www.albioma.com

ALBIOMA SHARES ARE LISTED ON NYSE EURONEXT PARIS (SUB B) AND ELIGIBLE FOR DEFERRED SETTLEMENT SERVICE (SRD) AND PEA-PME

ISIN FR0000060402 - TICKER ABIO